Simplex Trading’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,200
Closed -$7K 9379
2024
Q1
$7K Buy
+2,200
New +$4.84K ﹤0.01% 7838

Simplex Trading's LVTX Position: Q4 2024 in Review

Simplex Trading sold out of LAVA Therapeutics (LVTX) in Q4 2024, closing a stake of 51 shares.

Simplex Trading first reported a position in LVTX in Q2 2023 and held it in 6 quarters. The position peaked at $8K in Q1 2024. 22 funds tracked by Wall St. Rank hold LVTX as of Q4 2024.

  • Simplex Trading reported no remaining LAVA Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 51 LAVA Therapeutics shares in Q4 2024.
  • Simplex Trading first reported a position in LAVA Therapeutics in Q2 2023 and held it in 6 quarters.
  • Simplex Trading's LAVA Therapeutics position peaked at $8K in Q1 2024.
  • 22 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.